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Introduction
External (surrogate) motion monitoring data, e.g., from
a pressure sensor in a waist belt, are commonly used to
facilitate image reconstruction of time-resolved computed
tomography (4DCT)[1]. In the GSI 4D treatment planning
system, TRiP4D, these data are required for 4D simula-
tion of dose delivery to mobile tumors with scanned ion
beams[2]. For each delivered raster point the surrogate sig-
nal is correlated to the respective phase of the 4DCT. Mo-
tion state identification (ID) can, e.g., be based on the rela-
tive signal amplitude, the time between successive breath-
ing cycles or the signal phase[2]. In this work, we assess
the impact of these methods on the 4D dose distribution for
irregular and regular breathing trajectories.
Materials and Methods
We performed 4D dose simulations for one patient using
four measured breathing trajectories (pressure sensor). One
regular cos2 motion acc. Lujan et al.[3] with a 3.6 s breath-
ing period was also included. Relative amplitude-based
(RB), time-based (TB) and phase-based (PB) motion state
ID was performed for each trajectory. The signals were
pre-processed with in-house software to obtain the relative
amplitude, time and signal phase for each breathing cycle.
The derived signals featured a fixed amplitude range (e.g.
0% to 100%) per cycle. State ID in TRiP4D was based on
the pre-processed trajectories using 14 equally distributed
motion states over the amplitude range. Irradiation tim-
ing was simulated for typical beam pauses and spill lengths
used at the Heidelberg Ion Therapy Center. The resulting
15 dose distributions were assessed with respect to dose
coverage (V95), over dose (V107) and dose homogeneity
(HI = D5 − D95). VX denotes the target volume fraction
receiving at least X% of the planned dose, DX is the dose
coveringX% of the target volume.
Results
Table 1 lists the resulting V95, V107 and HI values for the
different trajectories and state ID methods. V107 and HI in
all cases are larger for the RB method (less than 5% and
3%, respectively). While for the Lujan trajectory V95 val-
ues are similar for all state ID methods, differences of up to
9% occur for the irregular trajectories, e.g., for fraction 3.
Variability of all parameters between different breathing
trajectories due to modulated interplay patterns was also
observed, as expected.
trajectory method V95[%] V107[%] HI[%]
fraction 1
RB 92.7 11.9 15.1
TB 93.9 8.7 13.7
PB 94.1 9.4 13.6
fraction 2
RB 88.6 2.5 12.4
TB 93.1 2.3 11.6
PB 89.1 1.3 11.4
fraction 3
RB 80.3 10.5 17.2
TB 86.2 5.7 14.3
PB 89.3 8.0 14.9
fraction 4
RB 92.1 11.5 15.2
TB 88.8 6.5 14.3
PB 92.7 9.6 14.3
Lujan
RB 92.3 10.1 14.7
TB 93.7 5.3 12.6
PB 92.9 6.3 13.1
Table 1: V95, V107 and HI values for the 4D simulations
using different motion trajectories and state ID methods.
Discussion
In this study the employed state ID methods had a non-
negligible impact on the simulated 4D dose distribution,
especially for irregular motion trajectories. For the RB
method, frequency distributions of the motion state per
raster point featured pronounced maxima around the ex-
trema of the motion trajectory. This is a likely cause for the
dosimetric differences observed in this case w.r.t to the TB
and PB methods, especially in V107. It can be assumed that
the employed state ID method should ideally match the one
used during 4DCT reconstruction. However, these methods
are vendor-specific and can be difficult to access.
Conclusion
The selected motion state ID method in 4D treatment
simulations for scanned beam delivery can have a non-
negligible impact on the simulated 4D dose distributions.
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